Skip to main content

Advertisement

Log in

A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

A Commentary to this article was published on 06 November 2023

Abstract

Objective

To develop a bimodal nomogram to reduce unnecessary biopsies in breast lesions with discordant ultrasound (US) and mammography (MG) Breast Imaging Reporting and Data System (BI-RADS) assessments.

Methods

This retrospective study enrolled 706 women following opportunistic screening or diagnosis with discordant US and MG BI-RADS assessments (where one assessed a lesion as BI-RADS 4 or 5, while the other assessed the same lesion as BI-RADS 0, 2, or 3) from two medical centres between June 2019 and June 2021. Univariable and multivariable logistic regression analyses were used to develop the nomogram. DeLong’s and McNemar’s tests were used to assess the model’s performance.

Results

Age, MG features (margin, shape, and density in masses, suspicious calcifications, and architectural distortion), and US features (margin and shape in masses as well as calcifications) were independent risk factors for breast cancer. The nomogram obtained an area under the curve of 0.87 (95% confidence interval (CI), 0.83–0.91), 0.91 (95% CI, 0.87 – 0.96), and 0.92 (95% CI, 0.86–0.98) in the training, internal validation, and external testing samples, respectively, and demonstrated consistency in calibration curves. Coupling the nomogram with US reduced unnecessary biopsies from 74 to 44% and the missed malignancies rate from 13 to 2%. Similarly, coupling with MG reduced missed malignancies from 20 to 6%, and 63% of patients avoided unnecessary biopsies. Interobserver agreement between US and MG increased from – 0.708 (poor agreement) to 0.700 (substantial agreement) with the nomogram.

Conclusion

When US and MG BI-RADS assessments are discordant, incorporating the nomogram may improve the diagnostic accuracy, avoid unnecessary breast biopsies, and minimise missed diagnoses.

Clinical relevance statement

The nomogram developed in this study could be used as a computer program to assist radiologists with detecting breast cancer and ensuring more precise management and improved treatment decisions for breast lesions with discordant assessments in clinical practice.

Key Points

Coupling the nomogram with US and mammography improves the detection of breast cancers without the risk of unnecessary biopsy or missed malignancies.

The nomogram increases mammography and US interobserver agreement and enhances the consistency of decision-making.

The nomogram has the potential to be a computer program to assist radiologists in identifying breast cancer and making optimal decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ACR:

American College of Radiology

AUC:

Area under the curve

BI-RADS:

Breast Imaging Reporting and Data System

CEUS:

Contrast-enhanced US

CI:

Confidence interval

MG:

Mammography

OR:

Odds ratio

ROC:

Receiver operator characteristic curve

SWE:

Shear wave elastography

US:

Ultrasound

References

  1. Lawson MB, Bissell M, Miglioretti DL et al (2022) Multilevel factors associated with time to biopsy after abnormal screening mammography results by race and ethnicity. JAMA Oncol 8:1115–1126

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ohuchi N, Suzuki A, Sobue T et al (2016) Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet 387:341–348

    Article  PubMed  Google Scholar 

  3. Rebolj M, Assi V, Brentnall A, Parmar D, Duffy SW (2018) Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis. Br J Cancer 118:1559–1570

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mann RM, Athanasiou A, Baltzer PA et al (2022) Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol 32:4036–4045

    Article  PubMed  PubMed Central  Google Scholar 

  5. Goh JHL, Tan TL, Aziz S, Rizuana IH (2022) Comparative study of digital breast tomosynthesis (DBT) with and without ultrasound versus breast magnetic resonance imaging (MRI) in detecting breast lesion. Int J Environ Res Public Health 19:759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Berg WA, Blume JD, Cormack JB et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299:2151–2163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shen Y, Shamout FE, Oliver JR et al (2021) Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams. Nat Commun 12(1):5645

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Liu H, Zhan H, Sun D (2020) Comparison of 99mTc-MIBI scintigraphy, ultrasound, and mammography for the diagnosis of BI-RADS 4 category lesions. BMC Cancer 20(1):1–8

    Article  ADS  Google Scholar 

  9. Barba D, Leon-Sosa A, Lugo P et al (2021) Breast cancer, screening and diagnostic tools: all you need to know. Crit Rev Oncol Hematol 157:103174

    Article  PubMed  Google Scholar 

  10. Berg WA, Zhang Z, Lehrer D et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307(13):1394–1404

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Qian X, Pei J, Zheng H et al (2021) Prospective assessment of breast cancer risk from multimodal multiview ultrasound images via clinically applicable deep learning. Nat Biomed Eng 5(6):522–532

    Article  PubMed  Google Scholar 

  12. Shao SH, Li CX, Yao MH, Li G, Li X, Wu R (2020) Incorporation of contrast-enhanced ultrasound in the differential diagnosis for breast lesions with inconsistent results on mammography and conventional ultrasound. Clin Hemorheol Microcirc 74:463–473

    Article  PubMed  Google Scholar 

  13. Pu H, Zhang XL, Xiang LH et al (2019) The efficacy of added shear wave elastography (SWE) in breast screening for women with inconsistent mammography and conventional ultrasounds (US). Clin Hemorheol Microcirc 71:83–94

    Article  PubMed  Google Scholar 

  14. Luo S, Yao G, Hong Z et al (2019) Qualitative classification of shear wave elastography for differential diagnosis between benign and metastatic axillary lymph nodes in breast cancer. Front Oncol 9:533

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kajiwara Y, Oka S, Tanaka S et al (2023) Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2023.01.022

    Article  PubMed  Google Scholar 

  16. Wang XY, Cui LG, Feng J, Chen W (2021) Artificial intelligence for breast ultrasound: an adjunct tool to reduce excessive lesion biopsy. Eur J Radiol 138:109624

    Article  PubMed  Google Scholar 

  17. Raza S, Goldkamp AL, Chikarmane SA, Birdwell RL (2010) US of breast masses categorized as BI-RADS 3, 4, and 5: pictorial review of factors influencing clinical management. Radiographics 30:1199–1213

    Article  PubMed  Google Scholar 

  18. Xie Y, Zhu Y, Chai W et al (2022) Downgrade BI-RADS 4A patients using nomogram based on breast magnetic resonance imaging, ultrasound, and mammography. Front Oncol 12:807402

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cai Y, Zhu C, Chen Q, Zhao F, Guo S (2021) Application of a second opinion ultrasound in breast imaging reporting and data system 4A cases: can immediate biopsy be avoided? J Int Med Res 49:675881916

    Article  Google Scholar 

  20. Niu S, Huang J, Li J et al (2020) Application of ultrasound artificial intelligence in the differential diagnosis between benign and malignant breast lesions of BI-RADS 4A. BMC Cancer 20:1–7

    Article  Google Scholar 

  21. Hong AS, Rosen EL, Soo MS, Baker JA (2005) BI-RADS for sonography: positive and negative predictive values of sonographic features. AJR Am J Roentgenol 184:1260–1265

    Article  PubMed  Google Scholar 

  22. Tan PS, Ali MA, Eriksson M, Hall P, Humphreys K, Czene K (2021) Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: a population-based cohort study. Int J Cancer 148:1351–1359

    Article  CAS  PubMed  Google Scholar 

  23. Choi WJ, Han K, Shin HJ, Lee J, Kim E, Yoon JH (2021) Calcifications with suspicious morphology at mammography: should they all be considered with the same clinical significance? Eur Radiol 31:2529–2538

    Article  PubMed  Google Scholar 

  24. Rauch GM, Hobbs BP, Kuerer HM et al (2016) Microcalcifications in 1657 Patients with pure ductal carcinoma in situ of the breast: correlation with clinical, histopathologic, biologic features, and local recurrence. Ann Surg Oncol 23:482–489

    Article  PubMed  Google Scholar 

  25. Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD (2011) Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol 52:481–487

    Article  PubMed  Google Scholar 

  26. Kerlikowske K, Zhu W, Tosteson AN et al (2015) Identifying Women with dense breasts at high risk for interval cancer. Ann Intern Med 162:673–681

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tagliafico AS, Calabrese M, Mariscotti G et al (2016) Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: interim report of a prospective comparative trial. J Clin Oncol 34:1882–1888

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study has received funding by the National Natural Science Foundation of China (82271998 and 82071949), College Students’ Innovative Entrepreneurial Training Plan Program (202212121022), and Guangzhou Municipal Science and Technology Department: 2023 Key research and development plan projects (2023B03J1350).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Ge Wen or Yingjia Li.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Yingjia Li.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained (NFEC-2020-294).

Study subjects or cohorts overlap

No study subjects or cohorts have been previously reported.

Methodology

• Retrospective

• Diagnostic study

• Multicentre study

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 449 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Z., Lin, Y., Huo, J. et al. A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment. Eur Radiol 34, 2608–2618 (2024). https://doi.org/10.1007/s00330-023-10255-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-10255-5

Keywords

Navigation